4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0001209191-23-046002
Options or other derivatives
- Chief Commercial Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Powl Brian T. Chief Commercial Officer | 2023-08-14 | Grant or award · Option to purchase common stock | +200,000 | 200,000 | D | ||
Loading xslF345X05/doc4.xml…